TOKYO: Japan’s Prime Minister Shinzo Abe said Japan will soon approve the anti-viral drug Remdesivir for the treatment of coronavirus patients, in what will be the country’s first such decision amid the pandemic.
According to Kyodo News, a government official also separately that the drug will be approved as early as next month to treat patients with Covid-19, the respiratory illness caused by the novel coronavirus, as moves to develop therapeutic drugs and vaccines have been accelerating around the globe.
“The pharmaceutical approval (of Remdesivir) will be possible shortly,” Abe told a parliamentary session on Monday.
Remdesivir has been developed by US biopharmaceutical company Gilead Sciences Inc. as a possible treatment for Ebola.
A clinical test conducted by an international team on patients with severe Covid-19 symptoms will conclude this month.
The New England Journal of Medicine recently published a study showing the drug’s effectiveness in nearly 70 per cent of 53 coronavirus patients with severe symptoms, while it caused serious side-effects, such as deterioration of kidney function, in a quarter of them.
A spokesperson of the Japan unit of Gilead Sciences said, “We are currently conducting clinical tests and are focused on confirming the drug’s efficacy and safety.”
Once an application by Gilead Sciences is made, the Japanese government is set to fast-track its approval. This streamlining of the process — which involves postponing reports on domestic clinical tests to a later date — is available on condition that the drug has been approved in another country.
In Japan, the anti-influenza drug Avigan is also going through clinical tests on Covid-19 patients, which will last through June. A scientific study in China has shown its efficacy in treating the disease.
The Japanese government has requested Fujifilm Toyama Chemical Co., a group firm of Fujifilm Holdings Corp., to boost production of Avigan, also known as Favipiravir. As it is feared to cause birth defects, it cannot be administered to expecting mothers or those who may become pregnant. – Bernama
